ALNOV.PA - Novacyt S.A.

Paris - Paris Delayed Price. Currency in EUR
0.405
+0.025 (+6.58%)
As of 3:40PM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close0.380
Open0.382
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.382 - 0.405
52 Week Range0.356 - 0.840
Volume368,576
Avg. Volume213,853
Market Cap15.211M
Beta (3Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.225
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.27
  • Simply Wall St.4 days ago

    Novacyt SA (EPA:ALNOV): Are Analysts Optimistic?

    Novacyt SA’s (EPA:ALNOV): Novacyt S.A. develops and sells diagnostic products for cancer and infectious diseases. The company’s loss has recently broadened since it announced a -€5m loss in the full Read More...

  • Business Wire4 months ago

    Novacyt: Update on Unsecured Debt Facility

    AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of the €4.0m unsecured, anti-dilutive debt facility (the “Advance”) from a French institutional investor, into an unsecured Convertible Bond (the “Convertible Bond”) further to the announcement on 30 May 2018. The Convertible Bond will be issued on 30 June 2018 following the successful outcome of the Extraordinary General Meeting (EGM) on 11 June 2018, which granted the Company sufficient authorities to issue equity. The Convertible Bond will be issued in a single tranche with a maturity of three years and bears an annual interest rate of 7.4%.

  • Business Wire4 months ago

    Novacyt Launches New Product in Infectious Mononucleosis

    Regulatory News:

  • Novacyt Société Anonyme (EPA:ALNOV): Is Breakeven Near?
    Simply Wall St.5 months ago

    Novacyt Société Anonyme (EPA:ALNOV): Is Breakeven Near?

    Novacyt Société Anonyme’s (ENXTPA:ALNOV): Novacyt Société Anonyme develops and sells diagnostic products for cancer and infectious diseases. The €25.56M market-cap company announced a latest loss of -€5.44M on 31 DecemberRead More...

  • How Did Novacyt Société Anonyme’s (EPA:ALNOV) Earnings Growth Stack Up Against The Industry?
    Simply Wall St.6 months ago

    How Did Novacyt Société Anonyme’s (EPA:ALNOV) Earnings Growth Stack Up Against The Industry?

    Examining Novacyt Société Anonyme’s (ENXTPA:ALNOV) past track record of performance is an insightful exercise for investors. It allows us to reflect on whether or not the company has met orRead More...

  • Business Wire11 months ago

    Novacyt: Admission and First Day of Dealings on AIM

    Regulatory News: